Unlike in mouse colon epithelial cell lines, ACSS2 expression was not significantly different between KRAS mutants, nor was it significantly elevated in response to MEK inhibition in human isogenic CRC cell lines (data not shown). The gene discussed is ACSS2; the disease is colorectal carcinoma.